Diarrhea is a common side effect reflecting your body's adjustment to GLP-1 activation, but it is not a requirement for weight loss
This test analyzes genetic variants in 14 pathways and 150+ insights related to GLP-1 receptor sensitivity, appetite regulation, and metabolic response
Laboratory Investigation
The FDA Adverse Event Reporting System (FAERS) has received reports of pancreatitis in patients taking tirzepatide, but these reports do not prove causation, as patients with type 2 diabetes and obesity have inherently elevated baseline risk for pancreatitis independent of medication use
With the backing of modern medical research, GLP-1 - is a trusted, science-driven choice for those seeking a natural and effective approach to weight management and overall health. Manufactured in a GMP certified facility FDA Compliant Ingredients Suitable for all Results in as little as 1 week Long-term results and prevention of various diseases All ingredients are derived from Natural Plants, With No Animal Testing
PubMed Central, Maintz, L., et al